Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disorder worldwide with no curative therapy. The aim of this study was to investigate the hepatoprotective effects of a novel Trihoney against biochemical and histological manifestations of NAFLD in hypercholesterolemic rab...
Saved in:
Main Authors: | Hamad Abdulsalam Hamad Alfarisi, Muhammad Bin Ibrahim, Zenab B. Hamad Mohamed, Nuraniza Azahari, Asmah Hanim Bt. Hamdan, Che Anuar Che Mohamad |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2020/4503253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
by: Murat Kiyici, et al.
Published: (2003-01-01) -
Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Melanie D Beaton
Published: (2012-01-01) -
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
by: Roger F. Butterworth, et al.
Published: (2019-03-01) -
Update on Ppar𝜸 and Nonalcoholic Fatty Liver Disease
by: Gene P. Ables
Published: (2012-01-01) -
Diet and Lifestyle in Nonalcoholic Fatty Liver Disease
by: Roberto Martínez-Beamonte, et al.
Published: (2020-01-01)